SAN DIEGO – Biopharmaceutical companies and venture capitalists have become more likely in recent years to seek out and license drug “platform” technologies such as RNAi from universities, non-profit research institutes, and smaller biotechnology companies, a panel of tech-transfer experts said at a conference held here this week.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.